An update of fast-off dopamine D2 atypical antipsychotics.
Seeman
Philip
P
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001682:Biological Availability; D004298:Dopamine / Q000378:metabolism; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors; D046509:Tissue Culture Techniques
D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D017448:Receptors, Dopamine D2; D004298:Dopamine